SIGNiX traveled to Boston this month to exhibit at Dpharm’s Disruptive Innovations Conference for Life Sciences. Disruptive Innovations is about creating efficiency and utilizing technology within the Life Sciences industry.
According to our dedicated life sciences National Account Manager, Jessi Lanuza, the most noteworthy benefit that attendees learned about SIGNiX’s Independent E-Signature™ is how “light-weight” our cloud-based solution is compared to other vendors that require a heavy infrastructure and hardware tokens.
One highlight from the Disruptive Innovations conference is that we were able to take five minutes to present to attendees and other vendors. We discussed how SIGNiX is shaking up the traditional paper processes that burden clinical trials with unnecessary costs and sluggish mobility. In a highly regulated industry, like life sciences, SIGNiX’s Independent E-Signature™ solution excels in compliance, speed and cost-efficiency.
Watch our presentation below to get the full scoop.
To see how SIGNiX helped one of the top three clinical research organizations in the country save thousands and cut trial to market time from 58 days to 3-4 days, click here.
Sneak Peek: Our booth's grand prize giveaway was full of